Home > Store > Management & Leadership
New Players in Life Sciences Innovation, The: Best Practices in R&D from Around the World, The
- By Tomasz Mroczkowski
- Published Jul 15, 2011 by FT Press. Part of the FT Press Operations Management series.
- Copyright 2012
- Dimensions: 6" x 9"
- Pages: 352
- Edition: 1st
- Book
- ISBN-10: 0-13-211990-0
- ISBN-13: 978-0-13-211990-0
Register your product to gain access to bonus material or receive a coupon.
Product Author Bios
Tomasz Mroczkowski (Washington, DC) is full professor of International Business at American University's Kogod School of Business. He teaches international business and management in emerging economies in its MBA program, and teaches in the special masters program in biotechnology management at the ESCP-EAP business school in Paris, France. Mroczkowski researches innovation and business development in emerging economies, international outsourcing, and R&D globalization in the life science/biotech industries. He has been featured on NBC Nightly News, was interviewed by Tokyo Shinbun and Shinichi Shinbun, and contributed to The Asian Wall Street Journal and Japan Times.
The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.
|
1 of 1 people found the following review helpful
By
This review is from: The New Players in Life Sciences Innovation: Best Practices in R&D from Around the World, The (FT Press Operations Management) (Hardcover)
Customer review from the Amazon Vine™ Program (What's this?)
The premise of the book is very interesting - how will R&D in a critical domain evolve based on the key emerging trends and what are the best practices in the new landscape. Unfortunately, the book fails to live up to the promise.The first three chapters provide a very laborious, repetitive analysis of the emerging countries in life sciences. Based on various government reports and other observations, the author convinces the reader that the "usual suspects" of emerging markets (Brazil, India, China...) are involved in Life Sciences as well. Other than highlighting the role of Singapore as a key player - these three chapters does nothing to advance a reader's understanding of the changing landscape. While the author outlines three key emerging trends - clinical trials, drug discovery and formation of technology clusters, they lack a discussion on how the author identified these three areas to focus on. The dependence on a PriceWaterCooper analysis on the future... Read more
1 of 1 people found the following review helpful
By
This review is from: The New Players in Life Sciences Innovation: Best Practices in R&D from Around the World, The (FT Press Operations Management) (Hardcover)
Customer review from the Amazon Vine™ Program (What's this?)
This is first rate, within the limits of its aims. Those limits are that it is research-centered, focused on a specific industry and set of ecosystems, and descriptive rather than normative. It deserves a broader audience, which it is unlikely to get, primarily because of the absurdity of academic book publishing, where the very opposite of incentive pricing applies; the smaller the market, the higher the price, which reduces sales to the Average Reader and stiffs students in the case of textbooks and gouges college libraries for monographs and specialist works. At $49 hardback and $39 on Kindle, this won't be a best seller.It merits a broad readership because it captures not just the dynamics of life sciences but of general shifts in global business in many other sectors. The analysis is well-grounded, full of data and examples that are instructive and embedded in a clear structure and set of organizing themes. It is very rich in illustrations from sectors, companies and... Read more
1 of 1 people found the following review helpful
By
This review is from: The New Players in Life Sciences Innovation: Best Practices in R&D from Around the World, The (FT Press Operations Management) (Hardcover)
Customer review from the Amazon Vine™ Program (What's this?)
After manufacturing, software and IT enabled services, now it is the time for the Life Science Industry to experience the effects of Globalization. Tomasz Mrockzkowski shows how R&D in life sciences is shifting from the Western countries to new global powerhouses like China and India. He compares the emerging innovation systems and national policies of China, India, Singapore, South Korea, and Brazil and evaluates their strengths and weaknesses in Pharmaceuticals, R&D, clinical trials and infrastructure creation. The critical study of the developments in differenct countries across the world gives not only very useful statistics, but also provides the framework for companies as well as entrepreneurs to take advantage of the global shifts in growth.Strategies of the largest multinational pharmaceutical companies in their R&D collaborations with the developing world are explored in depth, which reveals how jobs as well as knowledge are now moving out from US and Europe to... Read more |
› See all 9 customer reviews...
Online Sample Chapter
Power Shifts in Global R&D and Innovation: What They Mean for Firms in Life Science Businesses
Table of Contents
Acknowledgments viii
About the Author ix
Chapter 1 Power Shifts in Global R&D and Innovation: What They Mean for Firms in Life Science Businesses 1
Chapter 2 The Race for the Best National Innovation System: Who Has the Most Effective Strategy 37
Chapter 3 A Reshuffling of Markets and Growth Opportunities 73
Chapter 4 Improving R&D Productivity: Contract Research and Discovery Collaborations with the New Players as Solutions 109
Chapter 5 Globalization of Clinical Trials: It Is Not Just About Slashing Costs 151
Chapter 6 Accelerating Innovation: Bioparks, Technology Zones, and Emerging Clusters 193
Chapter 7 Company Strategies of Global R&D Collaborations: From West Meets West to West Meets East 229
Chapter 8 The Future: The Expanding Universe of Global Innovation 269
Endnotes 303
Index 331
Sample Pages
Download the sample pages (includes Chapter 1 and Index)

This book includes free shipping!
This book includes free shipping!
eBook (Watermarked)
$59.99
$47.99
Includes EPUB, MOBI, and PDF
About eBook Formats
This eBook includes the following formats, accessible from your Account page after purchase:
EPUBThe open industry format known for its reflowable content and usability on supported mobile devices.
MOBIThe eBook format compatible with the Amazon Kindle and Amazon Kindle applications.
PDFThe popular standard, used most often with the free Adobe® Reader® software.
This eBook requires no passwords or activation to read. We customize your eBook by discretely watermarking it with your name, making it uniquely yours.
- Request an Instructor or Media review copy.
- Corporate, Academic, and Employee Purchases
- International Buying Options
Get access to thousands of books and training videos about technology, professional development and digital media from more than 40 leading publishers, including Addison-Wesley, Prentice Hall, Cisco Press, IBM Press, O'Reilly Media, Wrox, Apress, and many more. If you continue your subscription after your 30-day trial, you can receive 30% off a monthly subscription to the Safari Library for up to 12 months. That's a total savings of $199.

